PROM1 and neoplasm: Exogenous BMP7 treatment and augmentation of BMP7 signaling in TMZ-resistant GSCs inhibits self-renewal and migratory capacity, reduces mRNA expression of CD133, MGMT, and ATP-binding cassette drug effluxing transporters and induces senescence, thus sensitizing tumor cells to TMZ treatment.